₹ 2,612.73 Cr
2.01%
S&P BSE Healthcare TRI
INF200K01446
5000.0
1000.0
500
Tanmaya Desai, Pradeep Kesavan
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
SBI Healthcare Opportunities Fund - Regular Plan -Growth | 46.68 | 16.15 | 26.98 |
S&P BSE Healthcare TRI | 50.08 | 13.58 | 22.23 |
Equity
Debt
Others
The scheme seeks maximum growth opportunities through investments in Pharma stocks.
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 13.41 |
Max Healthcare Institute Ltd. | 6.91 |
Cipla Ltd. | 6.87 |
Divi's Laboratories Ltd. | 6.59 |
Lonza Group Ag | 5.18 |
Aether Industries Ltd. | 4.31 |
Mankind Pharma Ltd. | 4.09 |
Aurobindo Pharma Ltd. | 4.08 |
Jupiter Life Line Hospitals Ltd. | 3.9 |
Lupin Ltd. | 3.88 |
Sector | Holdings (%) |
---|---|
Healthcare | 92.23 |
Chemicals | 4.31 |
Others | 3.46 |
Scheme Name | 5Y (%) |
---|---|
SBI HEALTHCARE Opportunities Reg Gr | 26.98 |
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 27.6 |
ABSL Pharma and Healthcare Reg Gr | 0.0 |
Tata India Pharma & Healthcare Reg Gr | 25.17 |
UTI Healthcare Reg Gr | 24.81 |
Nippon India Pharma Fund Gr Gr | 26.37 |
Mirae Asset Healthcare Reg Gr | 27.12 |
LIC MF Healthcare Fund Reg Gr | 20.85 |
DSP Healthcare Reg Gr | 27.95 |
ITI Pharma and Healthcare Fund Reg Gr | 0.0 |